Franck Brinkhaus PhD Press Releases

Published on December 12, 2019 - 08:00 GMT

Distribution of GynTect® may reduce uncertainty about cervical cancer in the family planning phase

Survey by clinicians and Oncgnostics quantifies significant psychological distress by repetitive diagnostic cycles in cervical cancer follow-up testing. JENA, GERMANY, December 12, 2019 /⁨EINPresswire.com⁩/ -- Oncgnostics GmbH, a Jena/Germany based company, has developed GynTect® for precision detection of cervical cancer. GynTect® was tested and validated in clinical trials on more than 3,000 samples with a remarkable detection score of 100% in all cervical cancer cases. Moreover, GynTect® identifies all …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...

Published on December 3, 2019 - 19:52 GMT

Oncgnostics presents new clinical data on GynTect® Precision Dx for triage of unclear cervical cancer screening tests

Oncgnostics is presenting corresponding new clinical data in five presentations at EUROGIN from Dec 4, 2019 to Dec 7, 2019 in Monaco (France). JENA , GERMANY, December 3, 2019 /⁨EINPresswire.com⁩/ -- Oncgnostics GmbH, a Jena/Germany based company, has developed GynTect® for precision detection of cervical cancer. GynTect® was tested and validated in clinical trials on more than 3,000 samples with a remarkable detection score of 100% in all cervical cancer cases. Moreover, GynTect® identifies all relevant …

Distribution channels: Healthcare & Pharmaceuticals Industry, Science ...

Published on November 14, 2019 - 10:00 GMT

Biotech Alliances International Acts as Exclusive Financial Adviser to EpicentRx on its $35 Million Series D Financing

Biotech Alliances International, a Silicon Valley-based healthcare-focused investment bank acts as the exclusive financial adviser to San Diego based EpicentRx SAN FRANCISCO, CALIFORNIA, USA, November 14, 2019 /⁨EINPresswire.com⁩/ -- San Francisco and La Jolla, Calif. -- Biotech Alliances International, Inc., a Silicon Valley-based healthcare-focused investment bank, announced today that it acted as the exclusive financial adviser to EpicentRx, Inc. on its $35 million Series D financing. EpicentRx, a …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...

Published on October 22, 2019 - 10:00 GMT

Motion Capture Group Retains Biotech Alliances International to Raise Series A $15 Million Financing Round

Proceeds to be used for the clinical validation of pioneering real-world motion analysis solutions and MotionMarkers for chronic movement disorders . SAN FRANCISCO/HEIDELBERG, USA/GERMANY, October 22, 2019 /⁨EINPresswire.com⁩/ -- Motion Capture Group (MCG), a motion analysis and digital care company, today announced that it has exclusively contracted the investment bank Biotech Alliances International Inc. for its planned $15 million Series A capital raise. MCG is pioneering the discovery of clinically …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...

Published on November 29, 2018 - 11:00 GMT

Oncgnostics GmbH Presents New Clinical Data on GynTect® Precision Diagnostics at EUROGIN 2018

Oncgnostics will discuss new clinical data with gynaecological key opinion leaders at EUROGIN 2018 SAN FRANCISCO, CA, USA, November 29, 2018 /⁨EINPresswire.com⁩/ -- Oncgnostics GmbH presents new clinical data on GynTect® Precision Diagnostics for triage of unclear cervical cancer screening tests. Oncgnostics GmbH, a Jena/Germany based company, has developed GynTect® for precision detection of cervical cancer. GynTect® was tested and validated in clinical trials on more than 3,000 samples with a …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...

Published on October 8, 2018 - 09:00 GMT

Enlyton LLC retains Biotech Alliances International Inc. to Lead $15m Series A Capital Raise

Enlyton, LLC., has developed a molecular biomarker for colon cancer, and other solid cancers. SAN FRANCISCO, CALIFORNIA , SAN MATEO, October 8, 2018 /⁨EINPresswire.com⁩/ -- Biotech Alliances International, a Silicon Valley-based healthcare-focused investment bank, announced today that it will serve as the lead investment banker to Enlyton LLC for its Series A $15m capital raise. Enlyton, LLC., an Ohio, USA early-stage biotech company has developed a molecular biomarker for colon cancer, and other solid …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...

Published on October 2, 2018 - 10:06 GMT

Oncgnostics GmbH retains Biotech Alliances International Inc. to support global partnering and distribution strategy.

Cervical cancer is still a significant problem for patients and health care systems. SAN FRANCISCO, CALIFORNIA, USA, October 2, 2018 /⁨EINPresswire.com⁩/ -- Biotech Alliances International Inc., a Silicon Valley-based healthcare-focused investment bank, announced today that it will serve as the lead investment banker to Oncgnostics globalisation and partnering strategy. Early detection of cervical cancer is critical for patients health and survival. Current diagnostic methods are inefficient and fail …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...

Published on November 14, 2017 - 16:25 GMT

Sealantium Medical retains Biotech Alliances International to Lead Series B $10 Million Capital Raise

Company will use the proceeds to complete Phase III study, manufacturing scale up, and US/EU regulatory approval. SAN FRANCISCO, CALIFORNIA, USA, November 14, 2017 /EINPresswire.com/ -- Biotech Alliances International, a Silicon Valley-based healthcare-focused investment bank, announced today that it will serve as the lead investment banker to Sealantium Medical for its $10 million Series B capital raise. Sealantium Medical, an Israeli/US company, was established in 2011 by Prof. Orgad Laub and has …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...

The Newsroom of Biotech Alliances International INC